XML 29 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Note 10 - Investments in Marketable Securities
6 Months Ended
Jun. 30, 2020
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]

Note 10 – Investments in Marketable Securities

 

Our investments in marketable equity securities are carried at fair value with the changes in unrealized gains and losses recognized in our results of operations at each measurement date. Our investments in marketable debt securities are classified as available for sale securities and carried at fair value with the unrealized gains and losses recognized through accumulated other comprehensive income at each measurement date. Any credit related decline in fair market values of our available for sale debt securities are recorded in our results of operations through an allowance for credit losses. Realized gains and losses from securities sales are recognized in results of operations upon disposition of the securities using the specific identification method on a trade date basis. Refer to Note 11 for a description of the Company's methodology for determining the fair value of marketable securities.

  

Marketable securities and restricted marketable securities consist of the following (in thousands):

 

  

June 30, 2020

  

December 31, 2019

 
  

Amortized

Cost

  

Fair

Value

  

Amortized

Cost

  

Fair

Value

 

Investments available for sale:

                

Marketable equity securities

 $30,176  $112,114  $30,176  $152,453 

Restricted investments available for sale:

                

Corporate debt securities

  65,554   69,452   63,414   65,653 

Asset-based securities

  52,370   52,846   54,451   55,185 

U.S. Treasury securities

  13,366   14,134   13,379   13,410 

State and municipal securities

  12,819   13,156   12,922   13,158 
  $174,285  $261,702  $174,342  $299,859 

 

Included in the marketable equity securities are the following (in thousands, except share amounts):

 

  

June 30, 2020

  

December 31, 2019

 
  

Shares

  

Cost

  

Fair

Value

  

Shares

  

Cost

  

Fair

Value

 

NHI Common Stock

  1,630,642  $24,734  $99,013   1,630,642  $24,734  $132,865 

 

The amortized cost and estimated fair value of debt securities classified as available for sale, by contractual maturity, are as follows (in thousands):

 

  

June 30, 2020

  

December 31, 2019

 
  

Cost

  

Fair

Value

  

Cost

  

Fair

Value

 

Maturities:

                

Within 1 year

 $21,229  $21,249  $15,726  $15,767 

1 to 5 years

  89,640   92,620   88,314   90,408 

6 to 10 years

  32,965   35,444   40,126   41,231 

Over 10 years

  275   275   -   - 
  $144,109  $149,588  $144,166  $147,406 

 

Gross unrealized gains related to marketable equity securities are $82,126,000 and $122,290,000 as of June 30, 2020 and December 31, 2019, respectively. Gross unrealized losses related to marketable equity securities are $188,000 and $13,000 as of June 30, 2020 and December 31, 2019, respectively. For the three months and six months ended June 30, 2020, the Company recognized net unrealized gains of $20,053,000 and net unrealized losses of $40,339,000, respectively, for the changes in fair market value of the marketable equity securities in the interim condensed consolidated statements of operations. For the three months and six months ended June 30, 2019, the Company recognized net unrealized losses of $54,000 and net unrealized gains of $6,784,000, respectively, for the changes in fair market value of the marketable equity securities in the interim condensed consolidated statements of operations.

 

Gross unrealized gains related to available for sale marketable debt securities are $6,418,000 and $3,407,000 as of June 30, 2020 and December 31, 2019, respectively. Gross unrealized losses related to available for sale marketable debt securities are $939,000 and $167,000 as of June 30, 2020 and December 31, 2019, respectively. The Company’s unrealized losses in our available for sale marketable debt securities were determined to be non-credit related.

 

The Company has not recognized any credit related impairments for the six months ending June 30, 2020 and 2019.

 

For the marketable securities in gross unrealized loss positions, (a) it is more likely than not that the Company will not be required to sell the investment securities before recovery of the unrealized losses, and (b) the Company expects that the contractual principal and interest will be received on the investment securities.

 

Proceeds from the sale of available for sale marketable debt securities during the six months ended June 30, 2020 and 2019 were $19,823,000 and $30,103,000, respectively. Investment gains of $13,000 and $-0- were realized on these sales during the six months ended June 30, 2020 and 2019, respectively. No sales were reported for marketable equity securities for the six months ended June 30, 2020 and 2019, respectively.